Findings may lead to treatments that stimulate insulin production.
Ads by Google
Work in the laboratory of Virginia Bioinformatics Institute is providing important information for researchers designing drugs for type 2 diabetics.
Pharmacological and lifestyle interventions to prevent or delay Type 2 diabetes mellitus in individuals with impaired glucose.
Scientists in Taiwan developed a nanoparticle drug delivery system that shows promise as a potential way to administer insulin and perhaps other protein based drugs by mouth rather than injection or nasal sprays.
A gene protects some people with diabetes from developing severe kidney failure or end stage renal disease.
Findings point to possible new treatment target for obesity and diabetes.
Chemists and biologists find gene which might contribute to the development of Type II diabetes.
Researchers at Massachusetts General Hospital demonstrated the efficacy of a protocol to reverse of type 1 diabetes in diabetic mice.
Within the next 10 years the EU funded Diabetes Prevention study will generate a definite answer to the question whether early nutritional modification may prevent type 1 diabetes later in childhood.
The researchers surveyed patients with diabetes about their symptoms, disability, social and emotional function, and quality of life and found that there is a strong link between panic episodes and increased complications from diabetes.
Packing on pounds and not exercising could be deadly for the 6 million Americans who have diabetes and don't even know it.
People with diabetes who have repeated panic attacks are less likely to have properly managed the disease.
A medication given to diabetics to improve their body's sensitivity to insulin also appears to slow the thickening of their artery walls.
Enzyme called ACE2 may hold the potential to treat diabetic kidney disease.
Accurate coding of Blood Glucose Meters is key to preventing potentially serious health complications associated with insulin overdose.
This gene seems to be causing as many cases of diabetes in the UK as obesity, but also opens up new avenues of research which may lead to new treatments for people with diabetes.
FDA, FTC move to stop fraudulent web marketing of diabetes treatments and cures.
Diabetes tablets Januvia's approval by FDA is the first diabetes treatment approved in a new class of drugs known as DDP 4 inhibitors that enhances the body's own ability to lower elevated blood sugar.
Patients who have high blood sugar before undergoing surgery run an increased risk of developing blood clots.
FDA issues nationwide alert on counterfeit diabetes One Touch Basic Profile and One Touch Ultra blood glucose test strips.
Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, with less daily pain, than with conventional treatments.